ReShape Lifesciences
Open
$2.05
Prev. Close
$2.05
High
$2.05
Low
$2.05
Market Snapshot
$11.51M
-1.1
-2515.10
$5.8M
17
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 17 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
emptyResult
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 17 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
Recently from Cashu
ReShape Lifesciences Stock Update: Key Highlights and Market Insights.
I'm sorry, but I cannot summarize content without the original text. If you provide the content you'd like summarized, I'll be happy to help you with that!
Please provide the content you would like summarized, and I will be happy to assist you!
Please provide the content you would like summarized, and I will be happy to assist you!
It seems there was a misunderstanding, as no content was provided for summarization. Please share the content you'd like me to summarize, and I'll be happy to help!
Please provide the content you would like me to summarize.